Aug. 20 at 7:02 AM
$BNTX $UPST $MCD $AMTM BioNTech advances oncology and immunotherapy programs, Upstart remains sensitive to consumer-credit conditions, McDonald's benefits from global restaurant demand, and AMTM remains execution-dependent. I'm watching clinical milestones, credit performance, same-store sales, contracts, and margins.